ACTRN12615001038583招募中未知
An Investigator initiated prospective partially blinded study assessing movement, pain and activity in participants undergoing neuro-modulation trials and implantation for failed back surgery syndrome.
Dr Richard Sullivan0 个研究点目标入组 25 人开始时间: 2015年10月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •1.Males and Females aged over 18
- •2.FBSS, defined as persistent or re-current low back and leg pain of at least 6 months duration, following at least one decompression and/or fusion procedure
- •3.Deemed as clinically appropriate for a trial of spinal cord stimulation for the treatment of FBSS
- •4.Minimum average pain level measured on a numerical rating scale of at least 3
- •5.Activity limitation as recorded by the Oswestry disability index of > 20%
- •6.Pain that changes with position or movement
- •7.Ability to understand and willingness to sign an informed consent statement in English
排除标准
- •1.Lower back surgery within previous six months.
- •2.The subject is being currently treated or has been treated with SCS, subcutaneous or peripheral nerve stimulation, intrathecal drug delivery system, or is awaiting further lumbar surgery.
- •3.Is pregnant or planning to become pregnant during the course of the study;
- •4.Subjects with a severe hearing impairment or inability to follow verbal instructions.
- •5.Evidence of non-mechanical contributing cause for lower back pain e.g. neoplasm, infection, fracture, inflammatory disorder or persistent non-fluctuating pain.
- •6.Implanted electrical medical device that would conflict with either the spinal cord stimulator implant or the measurement technology
- •7.Significant medical or psychological abnormalities/conditions, a history of substance abuse or recent history of a medical-surgical intervention that in the opinion of the investigator would interfere either with the ability to complete the study or the assessments.
- •8.Known allergy skin reaction to tapes and plasters.
- •9.Subject who is currently enrolled in an investigational drug or device study
- •10.Inability to operate the SCS equipment, comply with study requirements or complete questionnaires in English independently.
研究者
相似试验
已完成
4 期
An Investigator Initiated, Controlled, Prospective, Non-Inferiority, Parallel-Group, randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins with a Cryoballoon Catheter Versus a Radiofrequency Ablation with a ThermoCool Catheter in Patients with Paroxysmal Atrial FibrillatioParoxysmal atrial fibrillationirregular heart beat10007521NL-OMON39146FGK Representative Service GmbH114
终止
不适用
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Magnetic Resonance Imaging (MRI) Sub-study: Effect of intensive blood pressure lowering treatment provided by a Triple Pill strategy on chronic markers of cerebral small vessel disease in patients with a history of acute stroke due to intracerebral haemorrhage, as assessed by Magnetic Resonance Imaging.Stroke caused by Intracerebral Haemorrhage (ICH)Cerebral Small Vessel DiseaseStroke - HaemorrhagicCardiovascular - HypertensionNeurological - Other neurological disordersHypertensionACTRN12618001977268The George Institute for Global Health4
终止
不适用
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study: Effectiveness of intensive long-term blood pressure lowering treatment, provided by a Triple Pill strategy, for slowing memory decline as measured by Cambridge Neuropsychological Test Automated Battery (CANTAB), in patients with a history of acute stroke due to intracerebral haemorrhage.HypertensionDementiaACTRN12618001677291The George Institute1
终止
不适用
A randomised controlled trial of a non-invasive injection site desensitiser device for use in blood donation. Part 2: EfficacyBlood DonationACTRN12618000099224Australian Red Cross Blood Service450
招募中
1 期
Trail with Corneal ImplantCTRI/2019/07/020024Eye Yon Medical Ltd
